Top compounds associated with response to MYO15B


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.23 6e-10
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.22 8e-09
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.21 1e-08
mRNA RITA CTRPv2 pan-cancer AAC 0.21 3e-08
mRNA YM-155 CTRPv2 pan-cancer AAC -0.22 3e-08
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 7e-08
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 1e-07
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 2e-07
mRNA AZD6244 CTRPv2 pan-cancer AAC 0.19 4e-07
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 5e-07
Download CSV